• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定量磁共振成像在非酒精性脂肪性肝病中的临床应用。

Clinical Application of Quantitative MR Imaging in Nonalcoholic Fatty Liver Disease.

机构信息

Department of Radiology, Kobe University Graduate School of Medicine.

出版信息

Magn Reson Med Sci. 2023 Oct 1;22(4):435-445. doi: 10.2463/mrms.rev.2021-0152. Epub 2022 May 18.

DOI:10.2463/mrms.rev.2021-0152
PMID:35584952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10552668/
Abstract

Viral hepatitis was previously the most common cause of chronic liver disease. However, in recent years, nonalcoholic fatty liver disease (NAFLD) cases have been increasing, especially in developed countries. NAFLD is histologically characterized by fat, fibrosis, and inflammation in the liver, eventually leading to cirrhosis and hepatocellular carcinoma. Although biopsy is the gold standard for the assessment of the liver parenchyma, quantitative evaluation methods, such as ultrasound, CT, and MRI, have been reported to have good diagnostic performances. The quantification of liver fat, fibrosis, and inflammation is expected to be clinically useful in terms of the prognosis, early intervention, and treatment response for the management of NAFLD. The aim of this review was to discuss the basics and prospects of MRI-based tissue quantifications of the liver, mainly focusing on proton density fat fraction for the quantification of fat deposition, MR elastography for the quantification of fibrosis, and multifrequency MR elastography for the evaluation of inflammation.

摘要

病毒性肝炎以前是慢性肝病的最常见病因。然而,近年来,非酒精性脂肪性肝病(NAFLD)的病例一直在增加,尤其是在发达国家。NAFLD 的组织学特征是肝脏脂肪、纤维化和炎症,最终导致肝硬化和肝细胞癌。虽然肝活检是评估肝实质的金标准,但已有报道称,超声、CT 和 MRI 等定量评估方法具有良好的诊断性能。肝脂肪、纤维化和炎症的定量有望在 NAFLD 的预后、早期干预和治疗反应的临床管理方面具有临床意义。本综述的目的是讨论基于 MRI 的肝脏组织定量的基础和前景,主要集中在质子密度脂肪分数用于脂肪沉积的定量、磁共振弹性成像用于纤维化的定量以及多频磁共振弹性成像用于炎症的评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14b/10552668/1584eb7463a6/mrms-22-435-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14b/10552668/001764279911/mrms-22-435-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14b/10552668/ef3f0c5b7db6/mrms-22-435-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14b/10552668/1b1c55aec6de/mrms-22-435-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14b/10552668/ae4d6630cc60/mrms-22-435-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14b/10552668/1584eb7463a6/mrms-22-435-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14b/10552668/001764279911/mrms-22-435-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14b/10552668/ef3f0c5b7db6/mrms-22-435-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14b/10552668/1b1c55aec6de/mrms-22-435-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14b/10552668/ae4d6630cc60/mrms-22-435-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14b/10552668/1584eb7463a6/mrms-22-435-g5.jpg

相似文献

1
Clinical Application of Quantitative MR Imaging in Nonalcoholic Fatty Liver Disease.定量磁共振成像在非酒精性脂肪性肝病中的临床应用。
Magn Reson Med Sci. 2023 Oct 1;22(4):435-445. doi: 10.2463/mrms.rev.2021-0152. Epub 2022 May 18.
2
MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.磁共振弹性成像可有效用于非酒精性脂肪性肝病患者肝纤维化和坏死性炎症活动的无创评估。
Eur J Radiol. 2018 Jan;98:82-89. doi: 10.1016/j.ejrad.2017.11.003. Epub 2017 Nov 11.
3
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.磁共振弹性成像与瞬时弹性成像在经活检证实的非酒精性脂肪性肝病患者纤维化检测及脂肪变性无创测量中的比较
Gastroenterology. 2017 Feb;152(3):598-607.e2. doi: 10.1053/j.gastro.2016.10.026. Epub 2016 Oct 27.
4
Comparison of Magnetic Resonance-Based Elastography and Ultrasound Shear Wave Elastography in Patients With Suspicion of Nonalcoholic Fatty Liver Disease.磁共振弹性成像与超声剪切波弹性成像在疑似非酒精性脂肪性肝病患者中的比较。
Ultrasound Q. 2023 Jun 1;39(2):100-108. doi: 10.1097/RUQ.0000000000000638.
5
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.磁共振成像比瞬时弹性成像更能准确地对非酒精性脂肪性肝病患者的脂肪变性和纤维化进行分类。
Gastroenterology. 2016 Mar;150(3):626-637.e7. doi: 10.1053/j.gastro.2015.11.048. Epub 2015 Dec 8.
6
Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver Disease.前瞻性评估弥散加权成像虚拟磁共振弹性成像在非酒精性脂肪性肝病患者中的应用。
J Magn Reson Imaging. 2022 Nov;56(5):1448-1456. doi: 10.1002/jmri.28154. Epub 2022 Mar 14.
7
Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future.非酒精性脂肪性肝病肝纤维化的无创性影像学生物标志物:现状与展望。
Clin Mol Hepatol. 2023 Feb;29(Suppl):S136-S149. doi: 10.3350/cmh.2022.0436. Epub 2022 Dec 12.
8
Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis.磁共振弹性成像生物标志物在无纤维化的情况下用于检测非酒精性脂肪性肝病的组织学改变。
Eur Radiol. 2021 Nov;31(11):8408-8419. doi: 10.1007/s00330-021-07988-6. Epub 2021 Apr 26.
9
Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.放射影像学在非酒精性脂肪性肝病和非酒精性脂肪性肝炎中的应用。
Clin Liver Dis. 2018 Feb;22(1):93-108. doi: 10.1016/j.cld.2017.08.005. Epub 2017 Oct 10.
10
The Combination of MR Elastography and Proton Density Fat Fraction Improves Diagnosis of Nonalcoholic Steatohepatitis.磁共振弹性成像联合质子密度脂肪分数对非酒精性脂肪性肝炎的诊断价值。
J Magn Reson Imaging. 2022 Aug;56(2):368-379. doi: 10.1002/jmri.28040. Epub 2021 Dec 25.

引用本文的文献

1
Advanced fibrosis leads to overestimation of steatosis with quantitative ultrasound in individuals without hepatic steatosis.在没有肝脂肪变性的个体中,晚期肝纤维化会导致定量超声对脂肪变性的高估。
Ultrasonography. 2024 Mar;43(2):121-131. doi: 10.14366/usg.23194. Epub 2023 Dec 11.
2
Clinical applications of artificial intelligence in liver imaging.人工智能在肝脏成像中的临床应用。
Radiol Med. 2023 Jun;128(6):655-667. doi: 10.1007/s11547-023-01638-1. Epub 2023 May 10.

本文引用的文献

1
Three-dimensional MR Elastography Depicts Liver Inflammation, Fibrosis, and Portal Hypertension in Chronic Hepatitis B or C.三维磁共振弹性成像描绘慢性乙型或丙型肝炎的肝脏炎症、纤维化和门静脉高压。
Radiology. 2021 Oct;301(1):154-162. doi: 10.1148/radiol.2021202804. Epub 2021 Aug 10.
2
Comparison of diffusion-weighted imaging and MR elastography in staging liver fibrosis: a meta-analysis.扩散加权成像与磁共振弹性成像在肝纤维化分期中的比较:一项荟萃分析。
Abdom Radiol (NY). 2021 Aug;46(8):3889-3907. doi: 10.1007/s00261-021-03055-2. Epub 2021 Mar 26.
3
T1ρ magnetic resonance imaging value as a potential marker to assess the severity of liver fibrosis: A pilot study.
T1ρ磁共振成像值作为评估肝纤维化严重程度的潜在标志物:一项初步研究。
Eur J Radiol Open. 2021 Jan 7;8:100321. doi: 10.1016/j.ejro.2021.100321. eCollection 2021.
4
Multiple organs involved in the pathogenesis of non-alcoholic fatty liver disease.多个器官参与非酒精性脂肪性肝病的发病机制。
Cell Biosci. 2020 Dec 7;10(1):140. doi: 10.1186/s13578-020-00507-y.
5
T1 mapping of the liver and the spleen in patients with liver fibrosis-does normalization to the blood pool increase the predictive value?肝纤维化患者肝脏和脾脏的T1映射——向血池归一化是否会增加预测价值?
Eur Radiol. 2021 Jun;31(6):4308-4318. doi: 10.1007/s00330-020-07447-8. Epub 2020 Dec 11.
6
MRI-Based Radiomics Models Developed With Features of the Whole Liver and Right Liver Lobe: Assessment of Hepatic Inflammatory Activity in Chronic Hepatic Disease.基于全肝和右肝叶特征开发的磁共振成像放射组学模型:慢性肝病中肝脏炎症活动的评估
J Magn Reson Imaging. 2020 Dec;52(6):1668-1678. doi: 10.1002/jmri.27197. Epub 2020 May 23.
7
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives.肝纤维化:机制概念与治疗视角。
Cells. 2020 Apr 3;9(4):875. doi: 10.3390/cells9040875.
8
Diffusion-weighted MRI-based Virtual Elastography for the Assessment of Liver Fibrosis.基于扩散加权磁共振成像的虚拟弹性成像用于评估肝纤维化。
Radiology. 2020 Apr;295(1):127-135. doi: 10.1148/radiol.2020191498. Epub 2020 Feb 11.
9
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.2017 年全球疾病负担研究:1990-2017 年 195 个国家和地区按病因划分的肝硬化全球、区域和国家负担:系统分析。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):245-266. doi: 10.1016/S2468-1253(19)30349-8. Epub 2020 Jan 22.
10
Medical liver biopsy: background, indications, procedure and histopathology.医学肝脏活检:背景、适应证、操作及组织病理学
Frontline Gastroenterol. 2020 Jan;11(1):40-47. doi: 10.1136/flgastro-2018-101139. Epub 2019 Mar 2.